The Microsoft cofounder commended his fellow billionaire for “how well he showed a lot of interest in the issues I brought up.”

Advocates for people with HIV are concerned the Biden administration will not fully implement a ruling that allows enlistment by healthy HIV-positive Americans, leaving the matter to Trump.

"Ignoring the drive to survive" may be one of the incoming administration's fatal flaws, but dirty tech money is gambling otherwise.

Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the development of life-saving treatments,

On election night, Donald Trump said he would “govern by a simple ... when he made “a commitment to eliminate the HIV epidemic in the United States within 10 years” by launching the federal ...

Four key decisions await Trump: reinstating the Mexico City Policy; withdrawing from WHO, abandoning the Pandemic Prevention Treaty and de-authorizing PEPFAR, the HIV prevention program.

When Donald Trump returns to the White House, he's expected to issue a series of orders with far-reaching impact on global health — from abortion services to support for the World Health Organization.

Experts are also concerned that the second Trump administration will spurn scientific best practice, spreading disinformation globally. They cite Trump’s nomination of Robert F Kennedy Jr, a prominent anti-vaccine campaigner, as health and human services secretary.

The Supreme Court has agreed to hear a legal challenge targeting the preventative care mandates of the Affordable Care Act, also known as Obamacare, in its upcoming term.

A PEPFAR PLEA — America’s largest global health program that fights HIV in the developing world expires in two months, and the Bush Institute is urging the incoming Trump administration to protect it, POLITICO’s Carmen Paun reports.

A new Supreme Court case attacking the Affordable Care Act may not put the core provisions of the law in danger — but if the litigants get their way, it would give President-elect Donald Trump a new mechanism to cripple HIV care in the United States,